The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Q46178748)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia |
scientific article |
Statements
1 reference
The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (English)
1 reference
Seok Lee
1 reference
Yoo-Jin Kim
1 reference
Nak-Gyun Chung
1 reference
Jihyang Lim
1 reference
Dong-Gun Lee
1 reference
Hee-Je Kim
1 reference
Chang-Ki Min
1 reference
Jong-Wook Lee
1 reference
Woo-Sung Min
1 reference
Chun-Choo Kim
1 reference
1 February 2009
1 reference
1 reference
115
1 reference
3
1 reference
561-570
1 reference
Identifiers
1 reference
1 reference